BPC-157 is stable in stomach acid and unlike other growth factors, its stable in water
Community sources describe starting conservatively at 0.25 mg 3x weekly (0.75 mg total weekly) for the first 2-4 weeks the dual GLP-1/GIP mechanism can cause more intense initial GI side effects than single-target agonists
At a 4mg/mL concentration (10mg vial in 2.5mL BAC water), a 12mg weekly dose requires a 3mL injection volume which exceeds the practical limit for a single subcutaneous injection into most sites
BPC-157 is supplied in a 10mg lyophilised single-vial format (3ml vial), subject to stock availability
Comfort and Aftercare B12 injections are well tolerated, and a topical anaesthetic is rarely needed for a single deltoid dose, though the same comfort principles apply as with any injectable
How long the benefits last may depend on your individual needs, your B12 status, your metabolism, and the frequency of recommended injections